MedTrace Logo

Comparison of Brugger's Exercise With and Without Kendall Exercises in Sterno-Symphyseal Syndrome

NCT06407700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-12-27

No results posted yet for this study

Summary

Sterno-symphyseal syndrome is a natural result of prolonged sitting work, especially with computers .In actual it is the approximation between pubic symphysis and sternum. The aim of study will be to compare the effects of Brugger's exercise with and without Kendall exercises on Pain, Craniovertebral angle and Range of motion in patients with Sterno-Symphyseal Syndrome. Group A will be treated with Kendall exercises and Brugger's Exercise and Group B will receive Brugger's Exercise only. Standard treatment will be provided to both groups. Outcome measures will be conducted at baseline, after 3 weeks and by the end of 6 weeks of treatment. Data will be analyzed using SPSS software version 25.

Conditions

  • Upper Crossed Syndrome

Interventions

PROCEDURE

Brugger's exercise.

Participant was in a high sitting position. An elastic resistance band was be wrapped on each hand of the participant leaving the palm open and instructed to abduct and extend of thumb along with fingers, followed by wrist extension and forearm supination, the participant were instructed to perform scapular retraction with chin tucked in ,shoulder external rotation, elbow extension, shoulder abduction, and extension. Intervention was started from 10 seconds hold to 30 seconds with 2 seconds increment in every session. Rest time was 30 seconds, 4 sets 12 times repetitions.

PROCEDURE

Kendall Exercise.

Kendall exercises with the frequency 5 sets of consisting of 12 repetitions of postures, each taking 30 seconds,3 times a week for total of 6 weeks.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Tooba Jamil, MS OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-02
Primary Completion
2024-07-01
Completion
2024-08-04

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06407700 on ClinicalTrials.gov